Biorez
Dan Wagner is the current Director at Biorez. Prior to their current position, they were the Sr. Managing Director, Investments at Connecticut Innovations for 3 years and 10 months. Dan also served as a Board Observer for Tastes Natural, LLC for 1 year and 2 months, BEKHealth for 1 year, Artizan Biosciences, Inc. for 1 year and 6 months, Simcha Therapeutics for 2 years and 8 months, and Azitra Inc for 4 years and 2 months. Furthermore, they were a Board Member for Biorez for 6 years and 5 months, Tangen Biosciences, Inc. for 6 years and 6 months, and IsoPlexis for 7 years and 11 months. Lastly, they were a Board Observer for P2 Science, Inc. for 9 years and 3 months.
Dan Wagner has a Master of Business Administration from Quinnipiac University, a Venture Capital Institute 2008 certification, and a Master of Health Sciences from Quinnipiac University. Dan also has a degree in Biology from the University of Dayton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Biorez
Biorez is committed to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. They have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through their proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state.